Human Th2 but not Th9 cells release IL-31 in a STAT6/NF-κB-dependent way

Journal of Immunology

Volumn 193, Issue 2, 2014, Pages 645-654

  Maier, Elisabeth ^a   Werner, Dagmar ^a,b   Duschl, Albert ^a   Bohle, Barbara ^b   Horejs Hoeck, Jutta ^a  

^a UNIVERSITY OF SALZBURG   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 31; INTERLEUKIN 33; INTERLEUKIN 4; MESSENGER RNA; SMAD2 PROTEIN; SMAD3 PROTEIN; STAT6 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BINDING SITE; CD3+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOWN REGULATION; HELPER CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERLEUKIN 31 GENE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TH2 CELL; TH9 CELL;

BINDING SITES; BLOTTING, WESTERN; CELLS, CULTURED; DRUG SYNERGISM; GENE EXPRESSION; HUMANS; INTERLEUKINS; NF-KAPPA B; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STAT6 TRANSCRIPTION FACTOR; T-LYMPHOCYTES, HELPER-INDUCER; TH2 CELLS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84904263700     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301836     Document Type: Article

References (45)

1. Zhu, J., H. Yamane, and W. E. Paul. 2010. Differentiation of effector CD4 T cell populations. Annu. Rev. Immunol. 28: 445-489.
2. Wan, Y. Y., and R. A. Flavell. 2009. How diverse - CD4 effector T cells and their functions. J. Mol. Cell Biol. 1: 20-36.
3. Mosmann, T. R., H. Cherwinski, M. W. Bond, M. A. Giedlin, and R. L. Coffman. 1986. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136: 2348-2357. (Pubitemid 16136806)
4. Annunziato, F., and S. Romagnani. 2009. Heterogeneity of human effector CD4+ T cells. Arthritis Res. Ther. 11: 257.
5. Dardalhon, V., A. Awasthi, H. Kwon, G. Galileos, W. Gao, R. A. Sobel, M. Mitsdoerffer, T. B. Strom, W. Elyaman, I. C. Ho, et al. 2008. IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells. Nat. Immunol. 9: 1347-1355.
6. Veldhoen, M., C. Uyttenhove, J. van Snick, H. Helmby, A. Westendorf, J. Buer, B. Martin, C. Wilhelm, and B. Stockinger. 2008. Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat. Immunol. 9: 1341-1346.
7. Jones, C. P., L. G. Gregory, B. Causton, G. A. Campbell, and C. M. Lloyd. 2012. Activin A and TGF-beta promote T(H)9 cell-mediated pulmonary allergic pathology. J. Allergy Clin. Immunol. 129: 1000-1010.e3.
8. Temann, U. A., Y. Laouar, E. E. Eynon, R. Homer, and R. A. Flavell. 2007. IL9 leads to airway inflammation by inducing IL13 expression in airway epithelial cells. Int. Immunol. 19: 1-10. (Pubitemid 46017882)
9. Khan, W. I., M. Richard, H. Akiho, P. A. Blennerhasset, N. E. Humphreys, R. K. Grencis, J. Van Snick, and S. M. Collins. 2003. Modulation of intestinal muscle contraction by interleukin-9 (IL-9) or IL-9 neutralization: correlation with worm expulsion in murine nematode infections. Infect. Immun. 71: 2430-2438. (Pubitemid 36519854)
10. Erpenbeck, V. J., J. M. Hohlfeld, B. Volkmann, A. Hagenberg, H. Geldmacher, A. Braun, and N. Krug. 2003. Segmental allergen challenge in patients with atopic asthma leads to increased IL-9 expression in bronchoalveolar lavage fluid lymphocytes. J. Allergy Clin. Immunol. 111: 1319-1327. (Pubitemid 36683688)
11. Yao, W., R. S. Tepper, and M. H. Kaplan. 2011. Predisposition to the development of IL-9-secreting T cells in atopic infants. J. Allergy Clin. Immunol. 128: 1357-1360.e5.
12. Bullens, D. M., A. Kasran, E. Dilissen, K. De Swert, L. Coorevits, J. Van Snick, and J. L. Ceuppens. 2011. In vivo maturation of T(H) cells in relation to atopy. J. Allergy Clin. Immunol. 128: 234-237.e7.
13. Dillon, S. R., C. Sprecher, A. Hammond, J. Bilsborough, M. Rosenfeld-Franklin, S. R. Presnell, H. S. Haugen, M. Maurer, B. Harder, J. Johnston, et al. 2004. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat. Immunol. 5: 752-760. (Pubitemid 39023308)
14. Bilsborough, J., D. Y. Leung, M. Maurer, M. Howell, M. Boguniewicz, L. Yao, H. Storey, C. LeCiel, B. Harder, and J. A. Gross. 2006. IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis. J. Allergy Clin. Immunol. 117: 418-425. (Pubitemid 43190155)
15. Neis, M. M., B. Peters, A. Dreuw, J. Wenzel, T. Bieber, C. Mauch, T. Krieg, S. Stanzel, P. C. Heinrich, H. F. Merk, et al. 2006. Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis. J. Allergy Clin. Immunol. 118: 930-937. (Pubitemid 44498762)
16. Lei, Z., G. Liu, Q. Huang, M. Lv, R. Zu, G. M. Zhang, Z. H. Feng, and B. Huang. 2008. SCF and IL-31 rather than IL-17 and BAFF are potential indicators in patients with allergic asthma. Allergy 63: 327-332. (Pubitemid 351224674)
17. Stott, B., P. Lavender, S. Lehmann, D. Pennino, S. Durham, and C. B. Schmidt-Weber. 2013. Human IL-31 is induced by IL-4 and promotes TH2-driven inflammation. J. Allergy Clin. Immunol. 132: 446-454.e5.
18. Schulten, V., A. Radakovics, C. Hartz, A. Mari, S. Vazquez-Cortes, M. Fernandez-Rivas, I. Lauer, B. Jahn-Schmid, T. Eiwegger, S. Scheurer, and B. Bohle. 2009. Characterization of the allergic T-cell response to Pru p 3, the nonspecific lipid transfer protein in peach. J. Allergy Clin. Immunol. 124: 100-107.
19. Andrews, N. C., and D. V. Faller. 1991. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19: 2499.
20. Köhler, I., and E. P. Rieber. 1993. Allergy-associated I epsilon and Ec epsilon receptor II (CD23b) genes activated via binding of an interleukin-4-induced transcription factor to a novel responsive element. Eur. J. Immunol. 23: 3066-3071.
21. Hoeck, J., and M. Woisetschläger. 2001. Activation of eotaxin-3/CCLl26 gene expression in human dermal fibroblasts is mediated by STAT6. J. Immunol. 167: 3216-3222. (Pubitemid 32852561)
22. Lüthi, A. U., S. P. Cullen, E. A. McNeela, P. J. Duriez, I. S. Afonina, C. Sheridan, G. Brumatti, R. C. Taylor, K. Kersse, P. Vandenabeele, et al. 2009. Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 31: 84-98.
23. Mizushima, S., and S. Nagata. 1990. pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res. 18: 5322. (Pubitemid 20270119)
24. Maier, E., G. Wirnsberger, J. Horejs-Hoeck, A. Duschl, and D. Hebenstreit. 2007. Identification of a distal tandem STAT6 element within the CCL17 locus. Hum. Immunol. 68: 986-992.
25. + T cells is mediated by IL-4/STAT6 signaling. J. Biol. Chem. 286: 919-928.
26. Schmitz, J., A. Owyang, E. Oldham, Y. Song, E. Murphy, T. K. McClanahan, G. Zurawski, M. Moshrefi, J. Qin, X. Li, et al. 2005. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23: 479-490. (Pubitemid 41587888)
27. Guo, L., G. Wei, J. Zhu, W. Liao, W. J. Leonard, K. Zhao, and W. Paul. 2009. IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells. Proc. Natl. Acad. Sci. USA 106: 13463-13468.
28. Ali, S., M. Huber, C. Kollewe, S. C. Bischoff, W. Falk, and M. U. Martin. 2007. IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells. Proc. Natl. Acad. Sci. USA 104: 18660-18665. (Pubitemid 350210753)
29. Kakkar, R., and R. T. Lee. 2008. The IL-33/ST2 pathway: therapeutic target and novel biomarker. Nat. Rev. Drug Discov. 7: 827-840.
30. Chang, H. C., S. Sehra, R. Goswami, W. Yao, Q. Yu, G. L. Stritesky, R. Jabeen, C. McKinley, A. N. Ahyi, L. Han, et al. 2010. The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat. Immunol. 11: 527-534.
31. Goswami, R., R. Jabeen, R. Yagi, D. Pham, J. Zhu, S. Goenka, and M. H. Kaplan. 2012. STAT6-dependent regulation of Th9 development. J. Immunol. 188: 968-975.
32. Classen, S., T. Zander, D. Eggle, J. M. Chemnitz, B. Brors, I. Büchmann, A. Popov, M. Beyer, R. Eils, S. Debey, and J. L. Schultze. 2007. Human resting CD4+ T cells are constitutively inhibited by TGF beta under steady-state conditions. J. Immunol. 178: 6931-6940. (Pubitemid 46847419)
33. Hoeck, J., and M. Woisetschläger. 2001. STAT6 mediates eotaxin-1 expression in IL-4 or TNF-alpha-induced fibroblasts. J. Immunol. 166: 4507-4515. (Pubitemid 32233735)
34. Stritesky, G. L., R. Muthukrishnan, S. Sehra, R. Goswami, D. Pham, J. Travers, E. T. Nguyen, D. E. Levy, and M. H. Kaplan. 2011. The transcription factor STAT3 is required for T helper 2 cell development. Immunity 34: 39-49.
35. Stott, B., P. Lavender, S. Lehmann, D. Pennino, S. Durham, and C. B. Schmidt-Weber. 2013. Human IL-31 is induced by IL-4 and promotes TH2-driven inflammation. J. Allergy Clin. Immunol. 132: 446-454.e5.
36. Chang, H. C., S. Zhang, V. T. Thieu, R. B. Slee, H. A. Bruns, R. N. Laribee, M. J. Klemsz, and M. H. Kaplan. 2005. PU.1 expression delineates heterogeneity in primary Th2 cells. Immunity 22: 693-703. (Pubitemid 40814500)
37. Pai, S. Y., M. L. Truitt, and I. C. Ho. 2004. GATA-3 deficiency abrogates the development and maintenance of T helper type 2 cells. Proc. Natl. Acad. Sci. USA 101: 1993-1998.
38. Zhu, J., B. Min, J. Hu-Li, C. J. Watson, A. Grinberg, Q. Wang, N. Killeen, J. F. Urban, Jr., L. Guo, and W. E. Paul. 2004. Conditional deletion of Gata3 shows its essential function in T(H)1-T(H)2 responses. Nat. Immunol. 5: 1157-1165. (Pubitemid 39549630)
39. Heath, V. L., E. E. Murphy, C. Crain, M. G. Tomlinson, and A. O'Garra. 2000. TGF-beta1 down-regulates Th2 development and results in decreased IL-4-induced STAT6 activation and GATA-3 expression. Eur. J. Immunol. 30: 2639-2649.
40. Liew, F. Y., N. I. Pitman, and I. B. McInnes. 2010. Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat. Rev. Immunol. 10: 103-110.
41. Zhu, J., H. Yamane, J. Cote-Sierra, L. Guo, and W. E. Paul. 2006. GATA-3 promotes Th2 responses through three different mechanisms: induction of Th2 cytokine production, selective growth of Th2 cells and inhibition of Th1 cell-specific factors. Cell Res. 16: 3-10. (Pubitemid 43129303)
42. Raap, U., K. Wichmann, M. Bruder, S. Ständer, B. Wedi, A. Kapp, and T. Werfel. 2008. Correlation of IL-31 serum levels with severity of atopic dermatitis. J. Allergy Clin. Immunol. 122: 421-423.
43. Cornelissen, C., J. Lüscher-Firzlaff, J. M. Baron, and B. Lüscher. 2012. Signaling by IL-31 and functional consequences. Eur. J. Cell Biol. 91: 552-566.
44. Asnagli, H., M. Afkarian, and K. M. Murphy. 2002. Cutting edge: identification of an alternative GATA-3 promoter directing tissue-specific gene expression in mouse and human. J. Immunol. 168: 4268-4271. (Pubitemid 34441323)
45. Scheinman, E. J., and O. Avni. 2009. Transcriptional regulation of GATA3 in T helper cells by the integrated activities of transcription factors downstream of the interleukin-4 receptor and T cell receptor. J. Biol. Chem. 284: 3037-3048.